acyclovir
- Product NDC
- 68071-5100
- Requested package NDC
- 68071-5100-3
- 11-digit product format
- 680715100
- Labeler code
- 68071
- Product ID
- 68071-5100_1b46bf20-dfef-d52d-e063-6394a90aa986
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA077309
- Marketing category
- ANDA
- Marketing start
- 2006-03-13
- Marketing end
- 2026-12-31
- Substance
- ACYCLOVIR
- Active strength
- 800 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077309-001 | ACYCLOVIR | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | |
| A077309-002 | ACYCLOVIR | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077309-001 | AB |
| A077309-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A077309-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2005-09-29 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A077309-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2005-09-29 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A077309-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A077309-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077309-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077309-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A077309-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A077309-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077309-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077309-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077309-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077309-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077309-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077309-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077309-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077309-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077309-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077309-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077309-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077309-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A077309-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A077309-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077309-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077309-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077309-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077309-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077309-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077309-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A077309-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A077309-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077309-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077309-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A077309-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A077309-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A077309-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A077309-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A077309-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A077309-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A077309-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A077309-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A077309-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A077309-002 | AB | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- acyclovir
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACYCLOVIR | 800 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| X4HES1O11F | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 197313 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 968800dc-9456-a45f-e053-2995a90aa15e | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 33190c02-82e1-0a4d-d716-9ccd23588463 | Product name | 5 | 20250225 |
| c367d1da-5a72-8966-6d11-1eb9a73ae758 | Product name | 3 | 20231115 |
| 5518bf13-db2f-2e9c-3679-e70ecf03752c | Product name | 9 | 20210614 |
| 27897900-0e40-497b-97e1-88057e68fe6c | Product name | 4 | 20200710 |
| ca834e59-e669-229c-9288-0ccb76dc373e | Product name | 9 | 20200220 |
| d7f95c49-d3e1-4bbc-a389-e9cd73f59a28 | Product name | 1 | 20190702 |
| fb15b394-3715-4c87-a447-421489aa8739 | Product name | 3 | 20170727 |
| 7bdc4804-3832-c0df-e519-72b6d47c9792 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-08-20 | ACYCLOVIR TABLETS, USP 400 mg and 800 mg |
| 2023-01-30 | ACYCLOVIR TABLETS, USP 400 mg and 800 mg |
| 2021-02-22 | ACYCLOVIR TABLETS, USP 400 mg and 800 mg |
| 2021-01-29 | ACYCLOVIR TABLETS, USP 400 mg and 800 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5100-3 | acyclovir | 30 in 1 BOTTLE | TABLET | 30 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5100 | ACYCLOVIR TABLET [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240822_968800dc-9456-a45f-e053-2995a90aa15e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 499c6a98-0614-4ded-8526-909942bae8a4 | 2026-06-26 | Warnings, Adverse reactions | 077309 ANDA077309 |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | db35fce0-d7a3-4589-ba60-d78cdb1119cb | 2026-06-18 | Warnings, Adverse reactions | 077309 ANDA077309 |
| acyclovir | ACYCLOVIR | Apotex Corp. | 7fdeb609-24c4-5024-52c3-6a32bc7f3fcc | 2025-11-20 | Warnings, Adverse reactions | 077309 ANDA077309 |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | a7fd298b-3914-4316-8484-2d3ae188221a | 2024-08-12 | Warnings, Adverse reactions | 077309 ANDA077309 |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | ada4004a-c10a-6190-e053-2a95a90a5e67 | 2024-07-17 | Warnings, Adverse reactions | 077309 ANDA077309 |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | b2ae0432-bd2a-1480-e053-2a95a90a6fc8 | 2024-07-17 | Warnings, Adverse reactions | 077309 ANDA077309 |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 968800dc-9456-a45f-e053-2995a90aa15e | 2024-06-19 | Warnings, Adverse reactions | 077309 ANDA077309 68071-5100-3 68071-5100 68071510003 |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | bf1b4142-c5f3-4147-8224-bf6344566694 | 2024-05-30 | Warnings, Adverse reactions | 077309 ANDA077309 |
| acyclovir | ACYCLOVIR | Proficient Rx LP | 4c5a75fa-73db-4f48-895f-de1635d33f49 | 2021-01-01 | Warnings, Adverse reactions | 077309 ANDA077309 |
| acyclovir | ACYCLOVIR | Asclemed USA, Inc. | e186fdc9-b60e-4280-8d60-36cae9f2838f | 2020-09-25 | Warnings, Adverse reactions | 077309 ANDA077309 |
| acyclovir | ACYCLOVIR | Proficient Rx LP | 51052f0e-1a07-405a-a962-981ce9439e02 | 2020-02-01 | Warnings, Adverse reactions | 077309 ANDA077309 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197313 | acyclovir 800 MG Oral Tablet | PSN | 968800dc-9456-a45f-e053-2995a90aa15e | 3 |
| 197313 | acyclovir 800 MG Oral Tablet | SCD | 968800dc-9456-a45f-e053-2995a90aa15e | 3 |
| 197313 | acycycloguanosine 800 MG Oral Tablet | SY | 968800dc-9456-a45f-e053-2995a90aa15e | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-5100-3 | 68071510003 | 30 TABLET in 1 BOTTLE (68071-5100-3) | 30 tablet | 2006-03-13 | 2026-12-31 | No | No | Current |